Provided by Tiger Fintech (Singapore) Pte. Ltd.

GENSCRIPT BIO

17.210
+0.7004.24%
Volume:11.46M
Turnover:196.77M
Market Cap:37.62B
PE:1.59
High:17.500
Open:16.510
Low:16.410
Close:16.510
52wk High:19.400
52wk Low:8.880
Shares:2.19B
HK Float Shares:2.19B
Volume Ratio:2.59
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(LYR):10.848
ROE:-1.94%
ROA:2.56%
PB:1.10
PE(LYR):1.59
PS:5.85

Loading ...

Genscript Biotech (SEHK:1548): Reviewing Valuation After Analyst and Investor Day Update

Simply Wall St.
·
Yesterday

HK Stock Movement | GENSCRIPT BIO (01548) Drops Over 4% as Associate Legend Biotech Reports Narrowed Q3 Net Loss of $39.7M

Stock News
·
Yesterday

GenScript Biotech Affiliate Legend Biotech Reports Q3 2025 Financial Results

Reuters
·
Nov 12

Legend Biotech Q3 revenue slightly misses estimates

Reuters
·
Nov 12

Cabaletta Bio Appoints Steve Gavel as Chief Commercial Officer

Reuters
·
Nov 10

Genscript Biotech (01548) Announces Monthly Return for October 2025, Issued Shares Reach 2,185,678,939

Bulletin Express
·
Nov 04

GENSCRIPT BIO (01548): Legend Biotech to Present Latest Data at ASH Annual Meeting

Stock News
·
Nov 04

Genscript Biotech Corporation (1548) Announces Legend Biotech’s Data Presentation at 2025 ASH Meeting

Bulletin Express
·
Nov 04

Legend Biotech Unveils New CAR-T and Allogeneic Cell Therapy Data at ASH 2025

Reuters
·
Nov 04

Legend Biotech Corporation to Announce Third Quarter 2025 Results

Reuters
·
Oct 29

GENSCRIPT BIO (01548): CARVYKTI® Generates Net Trade Sales of Approximately $524 Million for Quarter Ended September 30, 2025

Stock News
·
Oct 14

Legend Biotech Announces FDA Approval of CARVYKTI® Label Update to Include Overall Survival Data and New Safety Warnings

Reuters
·
Oct 14

Legend Biotech Reports Preliminary CARVYKTI® Net Trade Sales of $524 Million for Q3 2025

Reuters
·
Oct 14

GENSCRIPT BIO (01548): Subsidiary Receives New Payment Under License Agreement with LM Pharma

Stock News
·
Oct 14

GenScript Biotech announces payment received under license agreement with LaNova Medicines

Reuters
·
Oct 14

Is Genscript Biotech Corporation (HKG:1548) Trading At A 44% Discount?

Simply Wall St.
·
Oct 11

US FDA adds boxed warning to J&J, Legend Biotech's cancer therapy

Reuters
·
Oct 11

Legend Biotech Signs Component and Product Supply Agreement with Janssen Pharmaceuticals for Cilta cel Manufacturing

Reuters
·
Oct 08

GENSCRIPT BIO (01548) Awards 775,000 Shares Under 2019 Restricted Share Unit Plan

Stock News
·
Sep 21

Genscript Biotech First Half 2025 Earnings: US$0.012 loss per share (vs US$0.046 loss in 1H 2024)

Simply Wall St.
·
Sep 14